Global Bank looking to MIT to help drive its digital journey for Risk & Controls framework, both at pace and at scale, with automated end-to-end processes and underlying key controls, positioning the bank as an industry leader in this space.
Looking for 8-10 startups to present their tech on April 12 at the 2022 MIT Health Science Technologies Conference: The Future of Cell & Gene Therapies.
A $17B/year global leader in automotive technologies, Faurecia is anticipating all the challenges of a changing industry. With the help of strategic partnerships with companies, start-ups and academia within an open innovation ecosystem, Faurecia technologies address two key aspects of mobility: the Cockpit of the Future for a safer, more comfortable, and more intuitive experience in the cockpit of the future, and Sustainable Mobility for cleaner and more environmentally-friendly transportation around the world. Owns more than 300 assembly lines in the US.
Takeda is looking for new approaches and technologies that can help them address challenges/opportunities in gastroenterology, oncology, neuroscience and rare genetic & hematology.
Evonik is looking for Battery Solutions to explore collaboration and investment opportunities.
Nissan Chemical Corporation is developing new manufacturing systems of large quantities of cell spheroids for regenerative medicines and drug discoveries and are now seeking potential collaborators for development of new applications of this system.
Work with MIT Reactor (MITR) scientists on real-time imaging of lithium-ion battery cells, binder removal from ceramic stereolithography green bodies, or analysis of hydrogen retention in irradiated metallic hydrides. To get started, contact Dr. Boris Khaykovich at bkh@mit.edu or 617.253.2681.